1. Home
  2. SVC vs LIMNW Comparison

SVC vs LIMNW Comparison

Compare SVC & LIMNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVC
  • LIMNW
  • Stock Information
  • Founded
  • SVC 1995
  • LIMNW N/A
  • Country
  • SVC United States
  • LIMNW United States
  • Employees
  • SVC N/A
  • LIMNW N/A
  • Industry
  • SVC Real Estate Investment Trusts
  • LIMNW
  • Sector
  • SVC Real Estate
  • LIMNW
  • Exchange
  • SVC Nasdaq
  • LIMNW Nasdaq
  • Market Cap
  • SVC N/A
  • LIMNW N/A
  • IPO Year
  • SVC N/A
  • LIMNW N/A
  • Fundamental
  • Price
  • SVC $3.03
  • LIMNW $0.35
  • Analyst Decision
  • SVC Strong Buy
  • LIMNW
  • Analyst Count
  • SVC 2
  • LIMNW 0
  • Target Price
  • SVC $6.00
  • LIMNW N/A
  • AVG Volume (30 Days)
  • SVC 1.5M
  • LIMNW N/A
  • Earning Date
  • SVC 08-05-2025
  • LIMNW N/A
  • Dividend Yield
  • SVC 1.38%
  • LIMNW N/A
  • EPS Growth
  • SVC N/A
  • LIMNW N/A
  • EPS
  • SVC N/A
  • LIMNW N/A
  • Revenue
  • SVC $1,895,857,000.00
  • LIMNW N/A
  • Revenue This Year
  • SVC N/A
  • LIMNW N/A
  • Revenue Next Year
  • SVC N/A
  • LIMNW N/A
  • P/E Ratio
  • SVC N/A
  • LIMNW N/A
  • Revenue Growth
  • SVC 0.80
  • LIMNW N/A
  • 52 Week Low
  • SVC $1.71
  • LIMNW N/A
  • 52 Week High
  • SVC $5.88
  • LIMNW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SVC 67.60
  • LIMNW N/A
  • Support Level
  • SVC $2.59
  • LIMNW N/A
  • Resistance Level
  • SVC $3.08
  • LIMNW N/A
  • Average True Range (ATR)
  • SVC 0.14
  • LIMNW 0.00
  • MACD
  • SVC 0.02
  • LIMNW 0.00
  • Stochastic Oscillator
  • SVC 90.74
  • LIMNW 0.00

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: